Mark Pruzanski
CIK 1559569 · President & CEO · last filed 2026-05-29
Mark Pruzanski is a President & CEO who has filed 82 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for EQ, was dated May 29, 2026. Across all open-market trades the lifetime net is −$52.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
82
-$51.98M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EQ | Director | — | $2.81 | — | $0 | 9 | 2026-05-29 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 718,894 | $19.00 | $13.66M | -$51.98M | 72 | 2021-12-02 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | EQ | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | EQ | Mixed | — | $0 | EDGAR |
| 2024-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −618,894 | -$11.76M | |
| 2023-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2022-05-25 | EQ | Grant (A) | — | $0 | EDGAR |
| 2021-12-02 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +2,321 | $39.9K | EDGAR |
| 2021-11-02 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +2,321 | $39.1K | EDGAR |
| 2021-10-04 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +2,320 | $34.5K | EDGAR |